提供者知道什么vs.提供者做什么:青少年避孕的障碍

Andrya J. Durr, BS, Elizabeth A. Critch, MBA, M. P. Fitzgerald, PhD, Kylie A. Fuller, MD, Kelly M. Devlin, MD, Roberta I. Renzelli-Cain, DO, MHS, NCMP, FACOG, IF
{"title":"提供者知道什么vs.提供者做什么:青少年避孕的障碍","authors":"Andrya J. Durr, BS, Elizabeth A. Critch, MBA, M. P. Fitzgerald, PhD, Kylie A. Fuller, MD, Kelly M. Devlin, MD, Roberta I. Renzelli-Cain, DO, MHS, NCMP, FACOG, IF","doi":"10.21885/wvmj.2021.9","DOIUrl":null,"url":null,"abstract":"INTRODUCTION The teenage birth rate in West Virginia (WV) remains among the highest in the United States. The American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) recommend long-acting reversible contraception (LARC) as first-line contraception. Because WV teenagers' LARC use is exceptionally low, the objective of this study was to gain insight into the current knowledge, practice, and beliefs of health care providers (HCP) in WV regarding LARC for adolescent patients. METHODS An electronic survey using Qualtrics.com was distributed to WV HCPs. Of the 2,196 HCPs contacted, 132 respondents returned the survey, and 109 completed usable data. RESULTS A majority of HCPs were aware that LARC (i.e., intrauterine devices and implantable devices) is the first line recommendation of the ACOG and AAP for adolescent birth control. However, HCPs most frequently prescribed combination oral contraceptives and injectables, which are not first-line recommendations. Notably, 59% of HCPs prescribing combination oral contraceptives believed they were prescribing according to COG and AAP recommendations. Forty-one percent of HCPs knew that combination oral contraceptives were not a first-line recommendation but prescribed them most often. The most frequently identified most important reason for not prescribing LARC was that the HCP did not know how to place them (16.5% of respondents), followed by litigious or malpractice action if there is a malfunction or complication (4.6% of respondents). DISCUSSION These results indicate a need to provide adequate LARC training to HCPs in WV.","PeriodicalId":23032,"journal":{"name":"The West Virginia medical journal","volume":"62 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"What Providers Know vs. What Providers Do: Barriers to Contraception in Adolescents\",\"authors\":\"Andrya J. Durr, BS, Elizabeth A. Critch, MBA, M. P. Fitzgerald, PhD, Kylie A. Fuller, MD, Kelly M. Devlin, MD, Roberta I. Renzelli-Cain, DO, MHS, NCMP, FACOG, IF\",\"doi\":\"10.21885/wvmj.2021.9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION The teenage birth rate in West Virginia (WV) remains among the highest in the United States. The American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) recommend long-acting reversible contraception (LARC) as first-line contraception. Because WV teenagers' LARC use is exceptionally low, the objective of this study was to gain insight into the current knowledge, practice, and beliefs of health care providers (HCP) in WV regarding LARC for adolescent patients. METHODS An electronic survey using Qualtrics.com was distributed to WV HCPs. Of the 2,196 HCPs contacted, 132 respondents returned the survey, and 109 completed usable data. RESULTS A majority of HCPs were aware that LARC (i.e., intrauterine devices and implantable devices) is the first line recommendation of the ACOG and AAP for adolescent birth control. However, HCPs most frequently prescribed combination oral contraceptives and injectables, which are not first-line recommendations. Notably, 59% of HCPs prescribing combination oral contraceptives believed they were prescribing according to COG and AAP recommendations. Forty-one percent of HCPs knew that combination oral contraceptives were not a first-line recommendation but prescribed them most often. The most frequently identified most important reason for not prescribing LARC was that the HCP did not know how to place them (16.5% of respondents), followed by litigious or malpractice action if there is a malfunction or complication (4.6% of respondents). DISCUSSION These results indicate a need to provide adequate LARC training to HCPs in WV.\",\"PeriodicalId\":23032,\"journal\":{\"name\":\"The West Virginia medical journal\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The West Virginia medical journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21885/wvmj.2021.9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The West Virginia medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21885/wvmj.2021.9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

西弗吉尼亚州(WV)的青少年生育率仍然是美国最高的。美国妇产科医师学会(ACOG)和美国儿科学会(AAP)推荐长效可逆避孕(LARC)作为一线避孕措施。由于WV青少年的LARC使用率非常低,本研究的目的是深入了解WV中卫生保健提供者(HCP)对青少年患者LARC的当前知识、实践和信念。方法使用Qualtrics.com进行电子问卷调查。在联系的2196名HCPs中,132名受访者回复了调查,109名完成了可用数据。结果大多数HCPs意识到LARC(即宫内节育器和植入式节育器)是ACOG和AAP对青少年节育的首选推荐。然而,卫生保健专业人员最常开出口服避孕药和注射剂的联合处方,这并不是一线建议。值得注意的是,59%的处方联合口服避孕药的医护人员认为他们是根据COG和AAP的建议开处方的。41%的医护人员知道复方口服避孕药不是一线推荐,但却是最常开的处方。不开LARC的最常见的最重要原因是HCP不知道如何放置它们(16.5%的受访者),其次是如果出现故障或并发症的诉讼或医疗事故诉讼(4.6%的受访者)。这些结果表明需要为WV的HCPs提供足够的LARC培训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
What Providers Know vs. What Providers Do: Barriers to Contraception in Adolescents
INTRODUCTION The teenage birth rate in West Virginia (WV) remains among the highest in the United States. The American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) recommend long-acting reversible contraception (LARC) as first-line contraception. Because WV teenagers' LARC use is exceptionally low, the objective of this study was to gain insight into the current knowledge, practice, and beliefs of health care providers (HCP) in WV regarding LARC for adolescent patients. METHODS An electronic survey using Qualtrics.com was distributed to WV HCPs. Of the 2,196 HCPs contacted, 132 respondents returned the survey, and 109 completed usable data. RESULTS A majority of HCPs were aware that LARC (i.e., intrauterine devices and implantable devices) is the first line recommendation of the ACOG and AAP for adolescent birth control. However, HCPs most frequently prescribed combination oral contraceptives and injectables, which are not first-line recommendations. Notably, 59% of HCPs prescribing combination oral contraceptives believed they were prescribing according to COG and AAP recommendations. Forty-one percent of HCPs knew that combination oral contraceptives were not a first-line recommendation but prescribed them most often. The most frequently identified most important reason for not prescribing LARC was that the HCP did not know how to place them (16.5% of respondents), followed by litigious or malpractice action if there is a malfunction or complication (4.6% of respondents). DISCUSSION These results indicate a need to provide adequate LARC training to HCPs in WV.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
COVID-19 Pandemic Effects on Seasonal Influenza Patterns in West Virginia COVID-19: West Virginia Essential Workers and the Risks They Face The Impact of COVID-19 Infection on Concurrent Traumatic Insults: An Analysis from the West Virginia Trauma System Catatonia Associated with Buprenorphine-Induced Toxic Leukoencephalopathy Recurrent Pneumothorax and a Solitary Pulmonary Nodule: A Case Report of a Rare Sequelae of Histoplasmosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1